Welcome to the NeurologyLive Mind Moments podcast.

 

In this episode, Daniel M. Hartung, PharmD, MPH, associate professor of pharmacy at Oregon State University College of Pharmacy, discusses findings of a report he and colleagues compiled on rising spending in the US Medicaid program on disease-modifying therapies for multiple sclerosis, and the unique nature of their prices in the United States. 

 

For more on MS and other neurology topics, visit NeurologyLive.com. Thanks for listening.